The optimal regimen of brentuximab vedotin for CD30+ cutaneous lymphoma: are we there yet?
Article
Overview
publication date
- December 18, 2017
published in
Research
keywords
- Immunoconjugates
- Ki-1 Antigen
Identity
Scopus Document Identifier
- 85038077725
Digital Object Identifier (DOI)
- 10.1111/bjd.16052
PubMed ID
- 29023638
Additional Document Info
has global citation frequency
volume
- 178
issue
- 2